Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Heidi M Mansour"'
Publikováno v:
International Journal of Nanomedicine, Vol 2009, Iss default, Pp 299-319 (2009)
Heidi M Mansour, Yun-Seok Rhee, Xiao WuUniversity of Kentucky, College of Pharmacy, Division of Pharmaceutical Sciences-Drug Development Division, Lexington, KY, USAAbstract: The lung is an attractive target for drug delivery due to noninvasive admin
Externí odkaz:
https://doaj.org/article/ff97a35e4408448295ebd08459f80133
Autor:
Basanth Babu Eedara, Bhagyashree Manivannan, Wafaa Alabsi, Bo Sun, Clara Curiel-Lewandrowski, Tianshun Zhang, Ann M. Bode, Heidi M. Mansour
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15515 (2023)
Nonmelanoma skin cancers (NMSC) are the most common skin cancers, and about 5.4 million people are diagnosed each year in the United States. A newly developed T-lymphokine-activated killer cell-originated protein kinase (TOPK) inhibitor, HI-TOPK-032,
Externí odkaz:
https://doaj.org/article/73468feafa0e4d67b776aa6f5d30dd14
Autor:
Christina Hoyer-Kimura, John P. Konhilas, Heidi M. Mansour, Robin Polt, Kristian P. Doyle, Dean Billheimer, Meredith Hay
Publikováno v:
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-17 (2021)
Abstract Background Decreased cerebral blood flow and systemic inflammation during heart failure (HF) increase the risk for vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer disease-related dementias (ADRD). We previous
Externí odkaz:
https://doaj.org/article/1f581aace31e48588560b1ea25934274
Autor:
Victor H. Ruiz, David Encinas-Basurto, Bo Sun, Basanth Babu Eedara, Eunmiri Roh, Neftali Ortega Alarcon, Clara Curiel-Lewandrowski, Ann M. Bode, Heidi M. Mansour
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 10, p 8776 (2023)
Cutaneous squamous cell carcinoma (cSCC) is the second-most common type of non-melanoma skin cancer and is linked to long-term exposure to ultraviolet (UV) radiation from the sun. Rocuronium bromide (RocBr) is an FDA-approved drug that targets p53-re
Externí odkaz:
https://doaj.org/article/9596381f09794d3698407834913313c0
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1870 (2022)
Central nervous system (CNS) disorders, such as psychiatric disorders, neurodegeneration, chronic pain, stroke, brain tumor, spinal cord injury, and many other CNS diseases, would hugely benefit from specific and potent peptide pharmaceuticals and th
Externí odkaz:
https://doaj.org/article/91c76ad3bb3441d79e3e59c520a93c8a
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1448 (2022)
For decades, vaccines have played a significant role in protecting public and personal health against infectious diseases and proved their great potential in battling cancers as well. This review focused on the current progress of therapeutic subunit
Externí odkaz:
https://doaj.org/article/6b41f113ce454f9cbdb0df910665a782
Autor:
Maria F. Acosta, Priya Muralidharan, Carissa L. Grijalva, Michael D. Abrahamson, Don Hayes, Jeffrey R. Fineman, Stephen M. Black, Heidi M. Mansour
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). Ad
Externí odkaz:
https://doaj.org/article/782a94f441384267b4d5f4dee94d1c2b
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 638 (2022)
Polymeric nanoparticles’ drug delivery systems represent a promising platform for targeted controlled release since they are capable of improving the bioavailability and tissue localization of drugs compared to traditional means of administration.
Externí odkaz:
https://doaj.org/article/8fe6f3265b2a484890cdb15e23a30fb2
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 587 (2022)
Heart failure (HF) causes decreased brain perfusion in older adults, and increased brain and systemic inflammation increases the risk of cognitive impairment and Alzheimer’s disease (AD). Glycosylated Ang-(1-7) MasR agonists (PNA5) has shown improv
Externí odkaz:
https://doaj.org/article/c1ba98e2d7d141afb2d236efee83736a
Autor:
Victor H. Ruiz, David Encinas-Basurto, Bo Sun, Basanth Babu Eedara, Sally E. Dickinson, Georg T. Wondrak, H. -H. Sherry Chow, Clara Curiel-Lewandrowski, Heidi M. Mansour
Publikováno v:
Pharmaceutics, Vol 14, Iss 4, p 700 (2022)
Nonmelanoma skin cancers (NMSCs) are the most common malignancies worldwide and affect more than 5 million people in the United States every year. NMSC is directly linked to the excessive exposure of the skin to solar ultraviolet (UV) rays. The toll-
Externí odkaz:
https://doaj.org/article/5dec1fdd371040b3a0b3f1228f26dddd